Badreddin Edris, Chief Operating Officer at SpringWorks Therapeutics, Inc. (SWTX), sold 40,000 shares at $42.24 ($1.7M) on 2024-12-03, disclosed to the SEC on 2024-12-05.
Scheduled sale ($1.7M) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.78 | 11,966 | $500K | 29.8% |
| 2 | $41.78 | 11,966 | $500K | 29.8% |
| 3 | $42.24 | 8,034 | $339K | 20.2% |
| 4 | $42.24 | 8,034 | $339K | 20.2% |
| Total | $41.96 avg | 40,000 | $1.7M | 100% |
| Filing → |
| SWTX | SELL | 2025-02-12 | $1.6M | — | Filing → |
| SWTX | SELL | 2024-09-04 | $1.1M | — | Filing → |
| SWTX | SELL | 2024-06-05 | $1.6M | — | Filing → |